Dostarlimab: The miracle drug for the treatment of colorectal cancer

被引:2
作者
Shuvo, Pollob Ahmed [1 ]
Tahsin, Anika [1 ]
Rahman, Md. Mominur [1 ]
Bin Emran, Talha [1 ,2 ]
机构
[1] Daffodil Int Univ, Fac Allied Hlth Sci, Dept Pharm, Dhaka 1207, Bangladesh
[2] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4381, Bangladesh
来源
ANNALS OF MEDICINE AND SURGERY | 2022年 / 81卷
关键词
Cancer; Colorectal cancer; Dostarlimab; Programmed cell death; Tumors;
D O I
10.1016/j.amsu.2022.104493
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 8 条
  • [1] [Anonymous], BAS INF COL CANC
  • [2] [Anonymous], 2014, Business Standard Newspaper
  • [3] [Anonymous], CANC DRUG HAD 100 SU
  • [4] [Anonymous], EC TIMES
  • [5] clinicaltrialsarena, JEMPERLI DOSTARLIMAB
  • [6] Dostarlimab: First Approval
    Markham, Anthony
    [J]. DRUGS, 2021, 81 (10) : 1213 - 1219
  • [7] ucir, DOSTARLIMAB GXLY JEM
  • [8] uptodate, COLORECTAL CANC EPID